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Abstract
The effects of long-term administration of boiled aqueous extract of Syzigium aromaticum (SYZ), 
commonly known as clove  (which has been locally employed for treating gastrointestinal tract diseases and also 
used as food spices), on some biochemical indices, such as body weight, liver functions and blood parameters 
were studied in adult albino rats of both sexes. Selected doses of 300 and 700 mg kg-1 were given orally through 
cannular to groups of animals for a period of 90 days, while the control group received distilled water throughout 
the duration of study via the same route. Blood samples collected after therapy and assayed for activities of some 
liver enzymes recorded a significant (p<0.05) and prominent effect on ALP and AST.  Measurement of 
haematological parameters also revealed significant effects (p<0.05; p<0.001) on Hb, RBC (p<0.05), PCV 
(p<0.001), platelets (p<0.001) and granulocytes (p<0.001).  An insignificant reduction was recorded for total 
WBC. The histopathological study conducted was in consonance with the results of the biochemical 
investigations that the aqueous extract of SYZ even at moderate doses, significantly affects body organs, their 
enzymes as well as the various functions. LD50 for both intraperitoneal and oral routes of SYZ were 263 and 
2500 mg kg-1 respectively. The present work has revealed the toxicity of sub chronic administration of SYZ, 
which suggests that its prolonged usage must be avoided. 
Key Words: Syzigium aromaticum, toxicity, biochemical parameters, haematological parameters, aqueous 
extract.
Introduction
Natural plant products have been used for therapeutic purposes since the time immemorial and their use 
is of a greater demand nowadays (Calixto, 2000).  Majority of the users rely on herbal medicines for health care 
because the other treatment options available are more expensive and they are often thought to be more 
associated with serious side effects.  Most of these plants have been ingested indiscriminately by many local 
populations for the management of various disease states without neither knowing how relief is brought about 
nor having adequate information on the safety/toxicity risks associated with their use.  For proper enlightenment 
and guidance of the populace, especially users of these natural products, there is need for scientific 
documentation on the safety/toxicity profile of these acclaimed medicinal plants. 
The indigenous medicinal plants in Nigeria form an important component of the natural wealth of the 
country and Syzigium aromaticum L. (family: Myrtaceae), formerly known as Eugenia caryophyllata,,
commonly known as Clove, and is one of the most widely used plants in this environment for medicinal 
purposes.  It is an evergreen tree in the Myrtle family and grows in warm climates but cultivated commercially in 
Tanzania, Sumatra, the Maluku (Molucca) Islands and South America (Bisset, 1994).  The tree grows up to 20 m 
and has leathery leaves.  Furthermore, the clove spice is the dried flower bud measuring between 12 to 22 mm in 
length, with 4 projecting calyx lobes folded to form a hood, which hides numerous stamens   (Dalziel, 1937).
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Twenty-two compounds have been identified in the extracts of clove buds with eugenol and eugenyl 
acetate as the major aroma constituents (Bensky et al., 2004).   Essential oils are obtained from the buds, stems 
and leaves (Lawless, 1995).  The essential oil from clove is used as a topical application to relieve pain and 
promote healing in herbal medicine (Prashar et al., 2006). Antioxidant activity found comparable to that of the 
natural antioxidant, vitamin E was documented (Lee and Shibamoto, 2001).  Eugenol was also reported to have 
strong acaricidal activity (Fichi et al., 2007), anthelmintic property (Balch and Balch, 2000) and anti-
inflammatory effect (Dip et al., 2004).  Its antibacterial and anticarcinogenic effects were independently 
observed by Burt and Reinders (2003) and Dorai and Aggarwal (2004).  Recently, Trongtokit et al., 2005 
showed that clove oil is an effective mosquito repellent.
Clove oil had long been recognized as safe and used in foods, beverages and tooth pastes, but toxicities 
which could be life-threatening were reported much later (Lane et al., 1991; Brow et al., 1992; PTCL 2005; and 
Prashar et al., 2006).  The systemic use of the essential oil has been restricted to three drops per day for an adult 
as excessive use can cause severe kidney damage (Bensky et al., 2004).
The dried bud of Syzigium aromaticum has a widespread use in this environment as a decoction 
macerated in water or occasionally lightly boiled in aqueous media for treating diverse ailments, especially, 
gastrointestinal disorders. Alternatively, it could be used as a concoction with other plants.  The dearth of 
information on the toxicity profile of the aqueous preparation of the bud necessitated the present investigation of 
its acute and sub-chronic ingestion in animal model.
Materials and Methods
Plant Materials and Preparation of Aqueous Extract
Dried buds of SYZ were purchased from Mushin market in Lagos metropolis, Lagos State, Nigeria.  
Plant authentication and extract preparation procedures have been earlier documented (Agbaje, 2008).
pH Determination of the Extract
The extract pH was determined using a pH meter (Cole Parmer, Chicago, Illinois 60648), under the 
required standard conditions.  The extract pH at 100 mg ml-1 was 4.6 ± 0.04
Experimental Animals
Healthy Swiss albino mice and Wistar rats of both sexes ranging between 15-20 g and 90-130 g 
obtained from the Laboratory Animal Centre of the College of Medicine were employed for the study. They 
were maintained under standard laboratory conditions all through the period of study and were fed on pelleted 
diet (Neimeth Nigeria Plc, Ikeja, Lagos State, Nigeria) and given tap water ad libitum.  Animals were kept in 
well-ventilated house conditions (room temperature range: 27ºC - 30ºC; photoperiod: 12 h natural light and 12 h 
dark; humidity: 50-55%). Experimental procedures were according to the Guidelines for Animal 
Experimentation as approved by the international, national and institutional guidelines for the Use and Care of 
Experimental Animals.
Acute Toxicity Test
A total of thirty overnight fasted mice (n = 5) were separately used for evaluating acute toxicity of SYZ. 
Doses of 100-520 mg kg-1 were administered intraperitoneally (i.p) and larger doses of 500-5000 mg kg-1 by oral 
gavage to separate groups of animals. Control group received 10 ml kg-1 distilled water via the same routes. The 
animals were observed for respiratory, GIT, CNS symptoms, behavioural patterns and mortality.  The LD50 was 
determined by graphical method (Miller and Tainter, 1944).
Sub-Chronic Toxicity Studies
Twenty four rats were randomly divided into three groups with Groups I  and II having six animals each, 
while Group III had twelve rats.  Prior to the commencement of investigation, the animals were fasted overnight 
but had access to drinking water at will.  Group I served as control and received 10 ml kg-1 water orally.  Group 
II received 300 and Group III 700 mg kg-1.  All the animals were kept on the scheduled treatment for 90 days.  
Group III was divided into A  and B of six rats each.  While the first half was sacrificed at the termination of 
drug therapy, the remaining animals were left for extra two weeks to assess the possible reversibility of the 
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toxicity of SYZ.  Body weights of the animals were monitored throughout the period of study and the mean 
values recorded.
Blood Collection and Bioassays
Blood samples for bioassays were obtained from rats by cardiac puncture under diethyl ether 
anaesthesia after 48 h of termination of treatment.  Blood samples for biochemical assays (liver and renal 
function tests) were collected into sterile plain bottles while those for haematological assay were collected into 
EDTA-treated sample bottles.  Haematological parameters-packed cell volume, total and differential white blood 
cell and platelet counts were analyzed using AdviaTM  60 closed tube (CT) Automated haematology System 
(Bayer Corporation, Tarrytown, New York, U.S.A).
The serum activities of liver enzymes alkaline phosphatase (ALP), was estimated by method of Sigma 
(1987), while those of Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were estimated by 
colorimetric method (Sigma Diagnostic, 1985).  Serum sodium and potassium were estimated by using clinical 
flame photometer at 410 ºC while urea was estimated by modified diacetylmonoamine method (Marsh, 1965).  
Estimation of serum creatinine was done by the Jaffe’s reaction method (Biod and Sirota, 1948).  The serum 
total protein was estimated by Biuret method (Treitz, 1970), while that of albumin was determined by 
bromocresol green (Lowry et al, 1957).  The total bilirubin and the conjugated bilirubin were determined by 
Jendrassik-Grof method (Spencer and Price, 1977).  The serum cholesterol was determined by Lierbermann 
quantitative test (1958).
Histopathological studies of selected vital Organs
Post-mortem examination was carried out on all the animals sacrificed as described above, and vital 
organs – liver, kidney, lungs, stomach, spleen, heart and brain were selected for histopathological study.  After 
blood rinsing in normal saline, sections were taken from each selected vital organ.  The tissues were fixed in 
10% formo-saline, dehydrated with 100% ethanol solution and embedded in paraffin.  It was then processed into 
4-5 µm thick sections stained with haematoxylin-eosin and observed under a microscope.
Statistical Analysis
Results were presented as mean ± S.E.M of six observations for each group.  Statistical analysis was 
made using two-ways analysis of variance using SYSAT 10.6 statistical software programme.  The values were 
considered significantly different when the p-value was less than 0.05.
Results
Acute toxicity study
It was observed that the animals treated with SYZ were generally normal.  Daily cage-side observations 
did not reveal any physical changes in the skin, fur, eyes, respiratory system and general behavioural patterns.  
The only toxic manifestation was abdominal writhing, however, a few animals died before the end of the study.  
LD50 was interpolated from the probit vs log-dose curve as 263.0 mg kg
-1 (i.p) and 2500.0 mg kg-1 (oral).
Effect of 90-days of oral treatment with SYZ on body weights of treated rats
 Body weight of all the SYZ treated animals increased in a dose dependent fashion with reference to the 
initial weight (Figure 1).  When compared with the control group however, the mean weight gained in the treated 
rats was significantly lower (p<0.05), (Figure 2). 
Effect of extract on weight of body organs
The effect of SYZ on weights of some vital body organs in rats showed no significant difference in the 
organ weight in both treated and control groups except that of stomach (p<0.05) (Figure 3).
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Haematological responses of rats to 90 days of oral treatment with SYZ
As shown in Table 1, repeated oral administration of SYZ to the treated rats caused significant effects on 
RBC (p<0.05), Hb (p<0.05; p<0.001), PCV (p<0.001), and platelets (p<0.001), while there was no significant  
effects on the total white blood count (TWBC), lymphocyte, and neutrophil counts (p>0.05) (Table 2).
Effects of the extract on serum electrolytes, urea and creatinine
SYZ caused a significant reduction (p<0.001) in the serum electrolytes as shown in Table 3, while 
inducing a significant increase (p<0.05) in the serum urea. Both changes occurred in the group assayed, two 
weeks after cessation of therapy.
Table 1: Effect of SYZ on the haematological parameters
DOSES (mg kg-1)
Blood       0      300              700            700 (Reversibility Test)
Parameter
PCV (%) 43.57 ± 2.36  46.72 ± 0.27    49.85 ± 0.42***, + 39.77 ± 1.06*, -
Hb (g/dl) 13.77 ± 0.52  14.40 ± 0.24*, + 15.40 ± 0.18***, +       12.36 ± 0.24*, -
MCH (pg) 18.73 ± 0.35  18.30 ± 0.26    18.35 ± 0.11             18.13 ± 0.15
MCHC (g/dl)  31.63 ± 0.38   31.03 ± 0.22     30.90 ± 0.09             30.87 ± 0.26
MCV (fl)  59.73 ± 0.80   58.74 ± 0.58      59.50 ± 0.54 58.73 ± 0.82
RBC (×106/µL) 7.45 ± 0.38   7.81 ± 0.17      8.36 ± 0.16*, + 6.77 ± 0.09
PLT (×103/µL) 535.17 ± 80.29 539 ± 102.78     868.00 ± 50.54***, +  607.00 ± 29.10
*, -  , ***, - represent significant decreases at p<0.05 and p<0.001 respectively when compared with control 
values;   
*, + , ***, + represent significant rise at p<0.05 and p<0.001, respectively, when compared with the control values.
Table 2: Effect of SYZ on total and differential WBC
DOSES (mg kg-1)
          0 300 700     700 (R)
Parameter
TWBC (×103/µL)    14.92 ± 1.73   15.13 ± 2.33 13.20 ± 1.88        9.60 ± 0.89
Lymph. (%)          9.13 ± 1.39 9.93 ± 3.02 8.05 ± 1.19    6.37 ± 0.83
Gran. (%)           2.13 ± 0.60 2.02 ± 0.47 2.20 ± 0.31     0.60±0.04***, -
Neutr. (%)           2.47 ± 0.32 1.87 ± 0.24 2.95 ± 0.38 2.37 ± 0.20
***, - represents a significant decrease at p<0.001 when compared to the control values.
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Table 3: Effect of SYZ on serum electrolytes, urea and creatinine in rats
DOSES (mg kg-1)
      0                  300     700 700 (R)
Parameter
Na+ (mEq/L) 172.67 ± 4.85  163.83 ± 6.13 167.00 ± 9.84     128.83 ± 1.33***, -
K+ (mEq/L) 9.72 ± 0.34  10.25 ± 1.00 9.50 ± 1.21     5.93 ± 0.37***,-
Cl- (mEq/L) 92.67 ± 2.39   88.83 ± 2.34 90.50 ± 2.91     94.00 ± 0.73
HCO3
- (mEq/L) 75.00 ± 3.79   69.00 ± 7.98*, -         69.50±14.09*, -      65.67±0.56***, -
Urea (mg/dL) 47.33 ± 2.49   44.33 ± 4.81 36.50 ± 1.12      50.17 ± 5.69*, +
Creat. (mg/dL) 1.00 ± 0.04    1.20 ± 0.22 0.90 ± 0.00       0.67 ± 0.02
*, -, *,+ represent significant decrease and rise, respectively, at p<0.05 while ***, - represents a significant 
decrease at p<0.001.
Table 4: Effect of SYZ on serum total proteins, cholesterol and conjugated bilirubin in rats
DOSES (mg kg-1)
0 300 700 700 (R)
Parameters
______________________________________________________________________________
Total proteins (g/dl) 8.07±o.17  6.83±0.21*,_   7.50±0.22   NR
Albumin (g/dl)  3.68±0.30   4.33±0.84    3.15±0.02    NR
Cholesterol (mg/dl)  68.17±5.74    57.83±8.10     70.00±6.26     59.33±1.12
Conj. Bilirubin (µmol/L)  0.67±0.02        0.50±0.04***,_     0.55±0.02*,_   0.45±0.07***,_
NR= not recorded; *, - represents a significant decrease at p<0.05 while ***, - represents a significant decrease at 
p<0.001.
Table 5: Effects of SYZ on liver enzymes in rats
DOSES (mg kg-1)
Liver enzyme 0 300 700 700 (R)
______________________________________________________________________________
ALP (IU/L) 0.35 ± 0.02    0.15 ± 0.02***, - 0.15 ± 0.02***, -   0.10 ± 0.00***, -
ALT (IU/L) 56.00 ± 2.25    51.00 ± 11.74     51.00 ± 2.68            60.33 ± 12.53
AST (IU/L) 62.33 ± 12.72     62.17 ± 28.86     93.50 ± 0.22***,+    58.33 ± 13.88***,_
***,+ ; ***, - represent significant rise and decrease, respectively, at p<0.001
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Table 6: Histological changes observed in the liver, spleen, brain, lungs, heart, testes and stomach of rats treated 
with SYZ for 90 days.
Organs Histological changes Grp I      Grp II       Grp IIIA     Grp IIIB
______________________________________________________________________________
Liver 1.  Steatosis   -       ++ +
2. Perivenular, periportal and 
sinusoidal inflammatory infiltrates    -         + ++     ++
Spleen Normal    -          - -       -
Brain 1.  Oedema              +        +           +++         +++
2.  Congestion                          -                 -           +++         +++
Lungs Patchy atelectasis             +       +            +              +
Heart Normal             -                 -               -               -
Kidney Tubular necrosis             -       -         ++ ++
Testes Normal             -                -              -                -
StomachGastritis             -               +         ++            ++
Key: - = no change; + = mild; ++ = moderate; +++ = severe      
Grp I = control; Grp II = low dose; Grp IIIA = high dose; Grp IIIB = reversibility test
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Figure 1: Effect of Oral SYZ on body weight changes during 90 days treatment. Data represent mean ± SEM of 
6 animals.  
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Figures 2: Effect of Oral SYZ on weight gain in rats after 90 days treatment. Data represent mean ± SEM of 6 
animals.  *Values compared with control significant at p<0.05.
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Figures 3: Effect of Oral SYZ on Organ weights. Data represent mean ± SEM of 6 animals. *Values compared 
with control significant at p<0.05.
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Figure 4: Brain Group II ×100: Showing mild oedema characterized by widening of space around blood vessels 
(thin arrow), reduced intensity of staining and friability of brain substance (thick arrow).
Figure 5: Kidney Group III ×400: Tubular necrosis (arrows).
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Figure 6: Liver Group I ×100: Showing normal morphology
Figure 7: Liver Group IIIA ×40: Showing perivenular, periportal and sinusoidal inflammatory infiltrates
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Figure 8: Liver Group IIIB ×400: Showing periportal inflammation
Figure 9: Stomach Group I ×40: Showing normal morphology
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Figure 10: Stomach Group IIIA ×40: Showing gastritis and tissue necrosis   
Effects of SYZ on the serum proteins, cholesterol, bilirubin and liver enzymes
The data obtained showed no significant effect on cholesterol and albumin, while a significant decrease 
in value was recorded for bilirubin (p<0.05; p<0.001) (Table 4).  On the other hand, SYZ exerted a prominent 
effect on both ALP and AST (p<0.001), while inducing no significant difference on ALT (p>0.05) (Table 5).
Histopathological effect of repeated oral administration of SYZ on selected vital organs
The spleen, heart, and testes did not reveal any morphological changes on gross and histological 
examinations. On the other hand, severe and irreversible toxicity was observed on the liver, brain, kidney and 
stomach (Table 6). 
Discussion
The result of acute oral toxicity recorded the LD50 of SYZ as 2500 mg kg
-1 which showed its relative 
safety as classified by the Organization for Economic Cooperation and Development (OECD, Paris-France) 
(Walum, 1998). On the other hand, i.p route recorded LD50 as 263 mg kg
-1. It could be conjectured that the 
herbal drug undergoes the first pass effect when administered orally. LD50 is not a biological constant because 
many variables such as animals’ species and strain, age, gender, diet, bedding, ambient temperature, caging 
conditions and time of the day can all affect its value; hence there are considerable uncertainties in extrapolating 
LD50 value obtained for a species to other species.  Consequently, LD50 test provides at best, only a ballpark 
estimate of human lethality (Zbinden and Flury-Roversi, 1981; Oduola et al., 2007).  
All the treated rats recorded much less body weight than the control group (Figure 2) and the percentage 
weight gain during the study period in Groups I, II, III A and B respectively are 428.1%, 350.0%, 160.6%, and 
139.0%.  Inability of the SYZ treated groups to gain as much weight as the water treated group might be due 
either to the effect of the extract on the internal organs (Figures 3 and 10), or to the general discomfort which led 
to a low feeding rate in the treated rats (Oyewole et al., 2007).   Administration of a chemical compound may 
bring about significant changes in the structure, function, metabolic transformation and concentration of 
biomolecules, enzymes and even metabolic pathways. These alterations, which may be rapid or slow may lead to 
different biochemical mechanisms producing similar pathological, clinical and laboratory findings (Murray et al., 
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2000).  Assessment of haematological parameters can be used to determine the extent of deleterious effect of 
foreign compound including plant extract on the blood.  It can also be used to explain blood relating functions of
chemical compound/plant extract.  Such laboratory investigations have been reported to be highly sensitive, 
accurate, and reliable and it remains the bedrock of ethical and rational research, disease diagnosis, prevention 
and treatment (Okonkwo et al, 2004; Yakubu et al., 2007). 
The extract significantly increased RBC, Hb and PCV, which was followed by a significant fall two 
weeks after cessation of therapy (Table 1). SYZ has been found to contain flavonoids (Agbaje, 2008), which are 
free radical scavengers.  It is therefore possible that these components compete with Hb in RBC for oxygen, 
resulting in hypoxia, which then stimulates synthesis and RBC production.  It is also possible that the end 
product of SYZ metabolism in the body stimulates the kidney directly to cause formation and secretion of 
erythropoietin, which is the humoral regulator of RBC production (Sanchez-Elsner et al., 2004).  Kobzik and
Schoen (1994), and Imoru et al. (2006) reported that interstitial pulmonary fibrosis is often associated with tissue 
anoxia, which in turn stimulates increased formation of ertthropoietin, a glycoprotein which stimulates increased 
RBC production. It is therefore very likely that SYZ contains erythropoietin-like principle(s), which is 
responsible for the high RBC and PCV values recorded in this study.
The calculated blood indices - MCV, MCH and MCHC have a particular importance in anaemia 
diagnosis in most animals (Coles, 1986).  The non-significant effect on these indices relating to RBC suggests 
that there was no effect on the average size of RBC and also on the haemoglobin weight per RBC.   This implies 
that the aqueous plant extract did not possess any potential of inducing anaemia throughout the period of 
treatment.
On the other hand, SYZ extract produced a non-significant reduction of TWBC at the higher dose level, 
the trend which was sustained even after cessation of therapy.  Similar reductions in granulocytes were also 
recorded.  It is projected that the extract contains some bioactive agents that could cause destruction or impair 
production of WBC.  It has been reported that granulocyte-macrophage colony stimulating factor, macrophage 
colony stimulating factor, interleukins IL-2, IL-4 and IL-5 regulate the proliferation, differentiation and 
maturation of committed stem cells responsible for the production of white blood cells (Guyton and Hall, 2000; 
Ganong, 2001).  It may be that some components of the extract reduced the production of these regulatory 
factors or interfered with the sensitivity of the committed stem cells (responsible for the production of white 
blood cells) to these factors (Adebayo et al., 2005)  Thus, administration of the extract may predispose to 
infection as it manifests immunosuppressive tendency. 
The significant elevation of platelets (p<0.001), is also an indication that SYZ at a very high dose could 
predispose its users to hypercoagulable state, hence, spontaneous intravascular clotting and thrombo-embolism. 
The Liver is one of the most important organs in the body and is responsible for breaking down all ‘poisons’ that 
enter the body and liver diseases could be mild or severe.  Liver function tests conducted through blood assays 
give information about the state of the liver, describing its functionality, e.g. albumin, cellular integrity, e.g. 
transaminases and its link with the biliary tract e.g. gamma-glutamyl transferase and alkaline phosphatase. ALT 
is the enzyme produced within the cells of the liver, recording increases in conditions where liver cells have been 
inflamed or undergone cell death.  As the cells are damaged, the ALT leaks into the bloodstream leading to a rise 
in the serum levels.  It is the most sensitive marker for liver cell damage. The present study showed a significant 
increase only in the levels of AST, a state which can be associated with cell necrosis of many tissues (Adedapo 
et al., 2004). The latter observation could be substantiated by the results of the histopathological study, which 
revealed the toxicity of SYZ on most of the body organ which could have consequently produced cell death.  
Toxicity could be attributed to the different secondary metabolites such as saponins, anthraquinones, tannins, 
cardiac glycosides and flavonoids present in SYZ (Agbaje, 2008).   A significant decrease in total protein level 
was recorded in group II animals that received 300 mg kg-1 SYZ (Table 4).  The fall in total protein may be due 
to poor nutrition, or malabsorption.   Furthermore, the effect of SYZ recorded on blood electrolytes showed that 
the herbal preparation significantly affects kidney function (Table 3). The renal biochemical alterations were 
corroborated by the histopathological changes of tubular necrosis (Figure 5). 
In conclusion, although SYZ has been reported by several workers to possess medicinal properties, this 
study however has shown that its indiscriminate and long-term use could be hazardous to body organs and it 
must therefore be ingested with caution. 
References
1. Adebayo J.O., Adesokan A.A., Olatunji L.A., Buoro D.O., and Soladoye A.O. (2005). Effect of ethanolic 
extract of Bougainvillea spectabilis leaves on haematological and serum lipid variables in rats. 
Biokemistri 17 (1): 45-50.
Agbaje et al.,  Afr. J. Trad. CAM (2009) 6 (3): 241 - 254 253
2. Adedapo A.A., Abatan M.O. and Olorunsogo O.O. (2004). Toxic effects of some plants in the genus 
Euphorbia on haematological and biochemical parameters of rats. Veterinarski Arhiv. 74(1): 53-62.
3. Agbaje E.O. (2008). Gastrointestinal effects of Syzigium aromaticum (L). Merr. & Perry (Myrtaceae) in 
Animal model. Nig. Qt. J. Hosp. Med. 18 (3): 137-141.
4. Balch P. and Balch J. (2000). Prescription for Nutritional Healing, 3rd  ed. Garden City Park, N.Y. Avery. 
ISBN 158330771.
5. Bensky D.S., Clavey S. and Stoger E.(2004). Chinese Herbal Medicine: Materia Medica. Seattle, W.A: 
Eastland Press. ISBN 0939616424.
6. Biod T. and Sirota B. (1948). In: Watson, A., et al. (Eds.), Practical Clinical Biochemistry, 4th ed. 
Prentice-Hall of India Private Ltd., New Delhi, India, pp. 142-145.
7. Bisset N. (1994). Herbal Drugs and Phytopharmaceuticals. Stuttgart, Germany, CRC Press, 130-131.
8. Brow S.A., Biggerstaff J. and Savidge G.F. (1992).Disseminated intravascular coagulation and 
hepatocellular necrosis due to clove oil. Blood Coagul. Fibrinolysis 3:665-668.   
9. Burt S.A. and Reinders R.D. (2003). Natural products and nutritional supplements. Appl. Microb. 36(3):
162-7.
10. Calixto J.B. (2000). Efficacy, Safety, Quality control, marketing and regulatory guidelines for herbal 
medicines (Phytotherapeutic agents). Braz. J. Med. & Biol Res. 33 (2): 179-189.
11. Coles E.H. (1986). “Veterinary Clinical Pathology.” W.B. Saunders, Philadelphia, U.S.A. pp. 10-42.
12. Dalziel J.M. (1937). The Useful Plants of West Tropical Africa. Crown Agents for the Colonies, London.
13. Dip E.C., Pereira N.A. and Fernandes P.D. (2004). Ability of Eugenol to reduce tongue edema induced by 
Dieffenbachia picta schott in mice.  Toxicon. 43: 729-735.
14. Dorai T. and Aggarwal B.B. (2004). Role of chemopreventive agents in cancer therapy. Cancer Lett. 215:
129-140.    
15. Fichi G., Flamini G., Giovanelli F., Otranto D. and Perrucci S. (2007). Efficacy of an essential oil of 
Eugenia caryophyllata against Psoroptes cuniculi.  Exp. Parasitol. 115 (2): 168-172.
16. Ganong W.F. (2001). Review of Medical Physiology. 20th Edition. Lange Medical Books. McGraw Hill 
Companies Inc., New York. Pp 500-515.
17. Guyton A.C., and Hall J.E., (2000). A Textbook on Medical Physiology. 10th Edition. W.B. Saunders 
Company, Philadelphia. Pp. 382-401.
18. Imoru, J.O., Eno A.E., Unoh F.B., Nkanu, E.E., Ofem. O.E. and Ibu J.O. (2006).Haematopoietic Agent(s) 
in the crude extract from the leaves of Viscum album (Mustletoe). Nig. J. Hlth.  Biom. Sc. 4 (2): 139-145.
19. Kobzik L. and Schoen F.J. (1994). The Lung. In: Cotran R.S., Kumar V., Robbins S.L. (Eds.): Robbins 
Pathologic Basis of Disease. 5th ed. W.B. Saunders Co., Philadelphia, U.S.A., pp. 673-734.
20. Lane B.W., Ellenhorn M.J., Hulbert T.V., McCarron M, (1991). Clove oil ingestion in an infant, Hum. 
Exp. Toxicol. 10 (4): 291-294.
21. Lawless J. (1995). The Illustrated Encyclopedia of Essential oils. Rockport, MA: Element. ISBN 
1852306610
22. Lee K.G. and Shibamoto T. (2001). Antioxidant property of aroma extract isolated from clove bud 
(Syzigium aromaticum (L). Merr. Et Perry). Food Chem. 74: 443-448.
23. Liebermann L.L. (1958). A method for the estimation of serum cholesterol. Clin. Chem. 2: 26-30.
24. Lowry O.H., Rosebrough N.J., Farr L. and  Randall R.J. (1957). Protein measurement with Folin phenol 
reagent. J. Biol.  Chem. 193: 265.
25. Marsh W.H. (1965). Automated and manual direct methods for the determination of blood urea. Clinical 
Chemistry 2: 624-625.
26. Miller L.C. and Tainter M.L. (1944). Estimation of the LD50 and its error by means of logarithmic probit 
graph paper. Proc. Sci. Expt. Biol. Med. 24: 839-840.
27. Murray R.K., Granner P.A., Mayer P.A., and Rodwell V.W. (2000). Harper’s Biochemistry. 20th edition. 
McGraw-Hill, pp. 594-602.
28. Oduola T., Adeniyi F.A.A., Ogunyemi E.O., Bello I.S., Idowu T.O., and Subair H.G. (2007). Toxicity 
studies on an unripe Carica papaya aqueous extract: biochemical and haematological effects in wistar 
albino rats. J. Med. Plant Res. 1 (1): 001-004
29. Okonkwo J.E., Iyadi K.C., and Effiong C.O. 2004). Effect of chronic administration of haematological 
parameters of rats. Nig. J. Physiol. Sc. 19 (1-2):10-13.
30. Oyewole I.O., Mogaji Z.J., Awoyinka O.A. (2007). Biochemical and Toxicological studies of aqueous 
extract of Tithonia diversifolia (Hemsl.) leaves in Wistar albino rats. J. Med. Plants Res. 1(2): 030-033. 
31. Prashar A., Locke I.C. and Evans C.S. (2006). Cytotoxicity of clove (Syzigium aromaticum) oil and its 
major components to human skin cells.  Cell Prolif. 39: 241-248.
32. Physical and Theoretical Chemistry Laboratory at Oxford (PTLC). 2005. Safety data for clove 
oil.Physical and Theoretical Chemistry Laboratory at Oxford. Retrieved April 6, 2008.
Agbaje et al.,  Afr. J. Trad. CAM (2009) 6 (3): 241 - 254 254
33. Sanchez-Elsner T., Ramirez J.R., Rodriguez-Sanz F., Varela E., Bernabew C. and Botella L.M. (2004). A 
cross talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SPI and 
smads. J. Mol. Biol. 36 (1): 9-24.
34. Spencer K. and Price C.P. (1977). Chemical analysis of bilirubin in biological fluids. Annals Clinical 
Biochemistry 14: 105-115.
35. Sigma Diagnostic, (1985). Transaminase (ALT/GPT) and (AST/GOT) Procedure No. 505.
36. Sigma Diagnostic, (1987). ALP Optimized Alkaline Phosphatase. Procedure No. DG 1245.
37. Treitz N.W. (1970). Fundamentals of Clinical Chemistry with Clinical Correlation. W.B. Sanders, 
Philadelphia, pp. 280-284.
38. Trongtokit Y.Y., Rongsriyan N., Komalamisra N. and Apiwathnasom L. (2005). Comparative repellency 
of 38 essential oils against mosquito bites. Phytother Res. 19(4): 303-9. 
39. Walum E. (1998). Acute oral toxicity. Environ. Health Perspect. 106: 497-503.
40. Yakubu M.T., Akanji M.A. and Oladiji A.T. (2007).  Hematological evaluation in male albino rats 
following chronic administration of aqueous extract of Fadogia agretis stem. PHCOG MAG ISSN 0973-
1296, pp. 34-38.
41. Zbinden G., and Flury-Rovers M. (1981). Significance of the LD50 test for toxicological evaluation of 
chemical substances. Arch. Toxicol. 49 (1): 99-103.
